Product correctly added to cart.

discount label
JH-RE-06
View 3D

Biosynth logo

JH-RE-06

CAS: 1361227-90-8

Ref. 3D-LEC22790

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 7 Jan 2025

Product Information

Name:
JH-RE-06
Description:

JH-RE-06 is a drug that can be used to treat cancer. It is an inhibitor of the enzyme topoisomerase II, which is needed for replication and transcription. The death of cancer cells is due to the inhibition of DNA replication and transcription by JH-RE-06. JH-RE-06 is also mutagenic and cisplatin treatment has been shown to increase its potency. This drug has been shown to have high specificity, with only a small number of cells showing resistance. JH-RE-06 can be used as part of a therapy regimen that includes cisplatin, which may be used in combination with other drugs in order to improve efficacy. The discovery of new hallmarks for cancer cells, such as the ability to sense light or respond to changes in acidity, may lead to better ways of monitoring cancer cells and detecting tumor formation at an early stage.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
468.72 g/mol
Formula:
C20H16Cl3N3O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-LEC22790 JH-RE-06

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".